This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the MISHA Knee System (Moximed Inc.) for treatment of medial compartment knee osteoarthritis.
Evidence Analysis
It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
- Does the technology improve health outcomes?
- Are there other benefits associated with the technology?
- What harms might be associated with the technology?
- Have patient selection criteria been established for the technology?
- For which patients might the technology provide a benefit?
- Health Technology Assessments
- Evidence Analysis Research Briefs
- Evolving Evidence Review
- Clinical Research Responses
Vibrant System (Vibrant Gastro Inc.) for Treatment of Chronic Idiopathic Constipation
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Vibrant System (Vibrant Gastro Inc.) for treatment of chronic idiopathic constipation.
Suprascapular Nerve Blockade for Treatment of Poststroke Hemiplegic Shoulder Pain
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of suprascapular nerve blockade for treatment of poststroke hemiplegic shoulder pain.
Lenire Bimodal Neuromodulation Device (Neuromod Devices Ltd.) for the Treatment of Tinnitus
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Lenire (Neuromod Devices Ltd.) bimodal neuromodulation device for the treatment of tinnitus symptoms.
Prolact+ H2MF (Prolacta Bioscience Inc.) Human Milk-Derived Human Milk Fortifier Products for Infants with Very Low Birth Weight
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Prolact+ H2MF (Prolacta Bioscience Inc.) human milk-derived human milk fortifier (HMF) for infants with very low birth weight (VLBW) to support healthy weight gain and help reduce gastrointe…
Platelet-Rich Plasma in the Surgical Repair of Achilles Tendon Rupture
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma in the surgical repair of Achilles tendon rupture.
Platelet Rich Plasma for Treatment of Achilles Tendinopathy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma for treatment of Achilles tendinopathy.
PulseSelect Pulsed Field Ablation (PFA) System (Medtronic Inc.) for Atrial Fibrillation
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the PulseSelect Pulsed Field Ablation system for treatment of atrial fibrillation compared with thermal catheter ablation.
TOPS System (Premia Spine) for Treatment of Symptomatic Lumbar Spondylolisthesis With Spinal Stenosis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the TOPS System (Premia Spine) for treatment of symptomatic lumbar spondylolisthesis with spinal stenosis.
RevitalVision Perceptual Learning Vision Training Program (Talshir Medical Technologies LTD) for Treatment of Amblyopia
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of RevitalVision for treatment of amblyopia in individuals aged 9 years or older.